Medical University of South Carolina Charleston HFpEF Conference 2024
45 $
Format : 18 videos + 1 pdf
File size: 7 GB
JULY 19-21, 2024
TARGET AUDIENCE
This course is intended for cardiovascular specialists, heart failure specialists, practicing cardiologists, cardiovascular advanced practice providers (NP or PA), internists, family physicians, pharmacist, cardiovascular nurses, critical care nurses, and industry representatives.
KNOWLEDGE GAPS
There are now more patients who have Heart Failure with preserved Ejection Fraction (HFpEF) than those with reduced Ejection Fraction (HFrEF). Making the diagnosis of HFpEF is more challenging than HFrEF as many commonly used screening tools such as physical
examination, echocardiography and measurement of natriuretic peptide levels are less sensitive and specifc in this population. Most importantly, no therapies have yet been shown to improve major cardiovascular outcome (i.e. reductions in hospitalization rates or lower
mortality). Several ongoing studies are evaluating novel treatments for this disorder.
CONFERENCE OBJECTIVES
At the completion of this conference, participants should be able to:
1. Review the latest evidence on the optimal choices of diuretics in heart failure.
2. Discuss new approaches to giving advice about sodium and fuid restriction in patients with heart failure.
3. Efectively prescribe medications for weight management in patients with HFpEF
4. Engage in shared decision making with your patients about the value of newer treatments
5. Discuss the mechanisms of diastolic dysfunction in patients with HFpEF
6. Design and implement a HF clinic for follow up of recently hospitalized HF patients
+ Topics: (There are some videos that were not recorded and released as scheduled)
HFpEF2024.pdf
Ask the Experts- Challenges in HFpEF Management and Diagnosis.mp4
Critical care issues in patients with HFpEF.mp4
Diuretic Therapy to Manage Congestion in HFpEF- Inpatient and Outpatient Strategies.mp4
Finding and Phenotyping HFpEF in the Cath Lab- Can We Personalize Our Treatments.mp4
HFpEF- Is it a Cardio-Metabolic Disease.mp4
HTN Management in the Prevention and Treatment of HFpEF.mp4
Implementation Strategies to Improve Care in Heart Failure.mp4
Importance of Skelatal Muscle in HFpEF- Implications for Weight Management.mp4
Management of Refractory Edema- a Primer for Heart Failure Providers.mp4
NAFLD and HFpEF- Pathophysiological Links and Treatment Implications.mp4
Pathophysiologic Insights in Cardiac Structure and Function- Application to Optimize Patient Selection for Interatrial Shunting.mp4
Pharmacological Approaches to Pulmonary Vascular Disease in HFpEF.mp4
Physical Therapy Intervention for Improving Outcomes and Preventing HF Hospitalization.mp4
Practical Tips for Managing Challenging, Real- World HFpEF Patients.mp4
Sex Diferences in Heart Failure.mp4
Targeting the nerves to improve outcomes in HFpEF- Renal artery, Pulmonary artery, and Greater Splanchnic nerve denervation.mp4
Top HFpEF Papers of the Year.mp4
Update on GLP1 Agonists and SGLT2 Inhibitors in HFpEF.mp4
Related Products
70 $
This product has multiple variants. The options may be chosen on the product page
